Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements (French, HTML)
Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements: French HTML file. From Health Canada, updated Jul 2021. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2021-07-27
The guidance document concerning amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19 indicates that the plain language labelling requirements for mock-up labels and a brand name assessment package do not apply (C.08.002(2)(j.1) and C.08.002(2)(o)). Although not required, sponsors are invited to provide a brand name assessment should one be available.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file